Add BrightSurf on Google Email

Tears could open a new avenue for diagnosing and monitoring eye and neurodegenerative diseases

Tear-derived extracellular vesicles show promise as non-invasive biomarkers for ocular and neurodegenerative diseases. The study highlights their potential to provide valuable information about the eye's health, including processes related to neurodegenerative diseases.

SourceGermans Trias i Pujol Research Institute·JournalExtracellular Vesicles and Circulating Nucleic Acids·TypeLiterature review·DateOct 22, 2025

Researchers find potential link between chronic pain, immune condition

A study led by Julie Pilitsis, MD, PhD, found a possible connection between chronic pain and eosinophilia, a white blood cell condition, in patients undergoing spinal cord stimulation or implanted pain medicine pumps. The study suggests that eosinophilia may be an immune biomarker for chronic pain.

SourceUniversity of Arizona Health Sciences·JournalNeuromodulation Technology at the Neural Interface·TypeData/statistical analysis·DateOct 9, 2025

ATR-FTIR spectroscopy for differentiating metaplastic breast carcinoma, ductal carcinoma in situ, and invasive ductal carcinoma

Researchers used ATR-FTIR spectroscopy to analyze tissue samples from patients with metaplastic breast carcinoma, ductal carcinoma in situ, and invasive ductal carcinoma. The study found that specific spectral features were significantly elevated in carcinomatous tissues and could effectively differentiate between normal tissue and can...

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateSep 30, 2025

Emerging serum biomarkers for chronic hepatitis B: Focus on serum HBV RNA and HBcrAg

Serum HBV RNA and HBcrAg have emerged as promising biomarkers for chronic hepatitis B, enabling better monitoring of disease progression, treatment response, and risk stratification. These markers provide a window into intrahepatic viral activity, correlating with clinical outcomes such as HCC development and liver fibrosis severity.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 30, 2025

Uncovering EUDAL – An RNA that shields oral cancer from drug therapy

A new study discovers a previously unknown long noncoding RNA, EUDAL, that helps oral cancer cells survive chemotherapy by permanently activating the epidermal growth factor receptor. This RNA molecule blocks the cellular tagging system, allowing EGFR to remain active and promote autophagy in cancer cells.

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalInternational Journal of Oral Science·TypeExperimental study·DateSep 30, 2025

Protein in urine can predict risk of dementia

A study published in Journal of Internal Medicine found that people with moderate to high levels of albumin in their urine have a higher risk of developing dementia. The researchers discovered an association between albuminuria and increased risk of dementia, independent of kidney function.

SourceKarolinska Institutet·JournalJournal of Internal Medicine·DateSep 23, 2025

AI model offers accurate and explainable insights to support autism assessment

A deep learning model achieved up to 98% accuracy in distinguishing autistic from neurotypical participants, providing clear insights into brain regions most influential to its decisions. The model could benefit autistic people and clinicians by offering accurate and explainable results to inform assessment and support.

SourceUniversity of Plymouth·JournalEClinicalMedicine·TypeComputational simulation/modeling·DateSep 18, 2025

Could boosting this molecule slow pancreatic cancer progression?

Researchers at Salk Institute and UC San Diego have identified a unique sugar called HSAT as a potential therapeutic target for slowing tumor progression and metastasis in pancreatic ductal adenocarcinoma. Boosting HSAT levels may slow the formation and spread of pancreatic cancer, leading to improved survival rates among patients.

SourceSalk Institute·JournalJournal of Clinical Investigation·DateSep 17, 2025

A practical tool to support harmonization and quality improvement in vitamin D testing

A new study published in Clinical Chemistry and Laboratory Medicine has developed a practical tool to support harmonization and quality improvement in vitamin D testing. The multicentre study evaluates the measurement uncertainty of various 25-(OH)D assays and their ability to detect physiologically relevant changes over time.

SourceInternational Osteoporosis Foundation·JournalClinical Chemistry and Laboratory Medicine (CCLM)·TypeExperimental study·DateSep 11, 2025

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer

Researchers have identified two molecular targets, HER2 and CD24, as promising candidates for new nuclear diagnostics and therapeutics for endometrial cancer. These targets may help clinicians identify patients likely to respond to targeted therapies, offering new hope for those with disseminated or recurrent disease.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·TypeExperimental study·DateSep 4, 2025

Ultra-high-gain MoS2 phototransistor enables room-temperature detection of few-photon signals and attomolar-level immunosensing

A team of scientists has unveiled a MoS2-based phototransistor that sets new records in optical gain and sensitivity. The device detects light pulses containing tens of photons and identifies disease biomarkers at attomolar concentrations, outperforming current gold standard assays.

SourceScience China Press·JournalScience Bulletin·TypeExperimental study·DateAug 21, 2025

Fast, accurate, low-cost diagnostics: No lab required

Researchers at Arizona State University have developed a rapid and accurate diagnostic test called NasRED that can detect diseases like COVID-19 with high sensitivity. The test uses tiny gold nanoparticles to identify disease-related proteins in a sample of bodily fluid, providing lab-quality accuracy without expensive equipment.

SourceArizona State University·JournalACS Nano·TypeExperimental study·DateAug 12, 2025

AI could soon detect early voice box cancer from the sound of your voice

Researchers have developed an AI system that can recognize the early warning stages of laryngeal cancer from voice recordings. By analyzing variations in tone, pitch, and volume, the AI can distinguish between voices with benign vocal fold lesions and those with cancer. The study's findings offer a promising breakthrough for non-invasi...

SourceFrontiers·JournalFrontiers in Digital Health·TypeExperimental study·DateAug 12, 2025

Brain Network Disorders Review explores biomarkers linked to rare autoimmune brain disease

Researchers identify key symptom categories and biomarkers for anti-NMDAR encephalitis, a rare autoimmune brain condition. Clinical manifestations suggest the presence of anti-NMDAR encephalitis through NMDA antibody checks, uric acid levels, C-reactive protein, and thyroid-related hormones.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateAug 8, 2025

New label-free 3D imaging technology offers breakthrough in diagnosing and treating lysosomal storage diseases

Researchers have developed a groundbreaking method to observe lysosomes in live suspended cells—quantitatively, in 3D, and without the use of chemical labels. The technology uses holographic tomography in flow cytometry configuration (HTFC) to identify morphological and spatial lysosomal changes in models of lysosomal storage diseases.

SourceFondazione Telethon·JournalACS Nano·TypeExperimental study·DateAug 6, 2025

Brown University neuroscientists help identify a biomarker for Alzheimer’s disease progression

Researchers at Brown University have identified a brain-based biomarker that can predict mild cognitive impairment development into Alzheimer's disease. They used a custom-built tool to analyze electrical activity from neurons and found distinct differences in beta events between patients who developed the disease and those who did not.

SourceBrown University·JournalImaging Neuroscience·TypeExperimental study·DateAug 4, 2025

GDF-15 and eGFRdiff: Predicting kidney risk and survival in diabetes mellitus

A new study found that two simple blood markers—eGFRdiff and GDF-15 levels—can independently predict kidney disease progression and mortality in people with diabetes. Patients with lower eGFRdiff values faced a higher risk of chronic kidney disease, while those with elevated GDF-15 levels were at increased risk of death.

SourceJuntendo University Research Promotion Center·JournalJournal of Cachexia Sarcopenia and Muscle·TypeObservational study·DateJul 29, 2025

Lipidomics study identifies cardiolipin dysregulation as a potential therapeutic target for bortezomib-induced peripheral neuropathy

A groundbreaking study found significant mitochondrial cardiolipin dysregulation in patients with bortezomib-induced peripheral neuropathy. The researchers identified diosmin as a promising candidate for targeting this condition, providing new avenues for therapeutic intervention.

SourceFAR Publishing Limited·JournalCurrent Pharmaceutical Analysis·DateJul 24, 2025